Bio-Rad Laboratories, Inc.
BIO
Hisse Senetlerindeki Sıralama
#2166
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Hisse Fiyatı
$352.07
Son senkronizasyon: 2026-10-19
Piyasa Değeri
$9.41B
Değişim (1 gün)
-0.23%
Değişim (1 yıl)
9.37%
Ülke
US
Ticaret Bio-Rad Laboratories, Inc. (BIO)
Kategori
Healthcare
Bio-Rad Laboratories, Inc. (BIO) için kazanç
Jun 2026 itibarıyla kazanç TTM: $350.40M
Bio-Rad Laboratories, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı $350.40M'dir. 2024 yılında şirket $-2.34B kazanç elde etti, bu 2023 yılındaki $-850.10M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Bio-Rad Laboratories, Inc. için kazanç geçmişi 2000 - 2026
Her yılın sonundaki kazanç
| Yıl | Kazanç | Değiştir |
|---|---|---|
| 2026 (TTM) | $350.40M | -64.80% |
| 2025 | $995.50M | -142.50% |
| 2024 | $-2.34B | 175.55% |
| 2023 | $-850.10M | -81.93% |
| 2022 | $-4.70B | -186.33% |
| 2021 | $5.45B | 10.80% |
| 2020 | $4.92B | 117.51% |
| 2019 | $2.26B | 345.66% |
| 2018 | $507.36M | 418.75% |
| 2017 | $97.81M | 135.33% |
| 2016 | $41.56M | -71.50% |
| 2015 | $145.85M | 10.86% |
| 2014 | $131.56M | 17.06% |
| 2013 | $112.39M | -51.47% |
| 2012 | $231.58M | -1.77% |
| 2011 | $235.76M | 7.03% |
| 2010 | $220.28M | 18.54% |
| 2009 | $185.83M | 30.10% |
| 2008 | $142.84M | 18.21% |
| 2007 | $120.84M | -14.92% |
| 2006 | $142.03M | 52.11% |
| 2005 | $93.37M | -4.06% |
| 2004 | $97.33M | -14.39% |
| 2003 | $113.69M | 8.89% |
| 2002 | $104.41M | 60.70% |
| 2001 | $64.97M | 42.97% |
| 2000 | $45.44M | 0.00% |
Benzer şirketler veya rakipler için kazanç
| Şirket | Kazanç | Kazanç Farkı | Ülke |
|---|---|---|---|
| $7.51B | 2,043.55% |
US
|
|
| $5.56B | 1,487.61% |
IE
|
|
| $5.15B | 1,369.18% |
US
|
|
| $3.86B | 1,001.88% |
US
|
|
| - | - |
DE
|
